NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
NovelStem International Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2013 | 0.5723M |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | 2.345M |
| September 30, 2011 | 2.581M |
| June 30, 2011 | 2.706M |
| March 31, 2011 | 2.568M |
| December 31, 2010 | 2.631M |
| September 30, 2010 | 2.599M |
| June 30, 2010 | 2.662M |
| March 31, 2010 | 2.616M |
| December 31, 2009 | 2.569M |
| September 30, 2009 |
| Date | Value |
|---|---|
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | 5.801M |
| June 30, 2008 | 6.606M |
| March 31, 2008 | 7.076M |
| December 31, 2007 | 7.272M |
| September 30, 2007 | 7.608M |
| June 30, 2007 | 7.838M |
| March 31, 2007 | 7.475M |
| December 31, 2006 | 7.491M |
| September 30, 2006 | 7.162M |
| June 30, 2006 | 6.822M |
| March 31, 2006 | 6.512M |
| December 31, 2005 | 5.885M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | 3.297M |
| Summit Therapeutics, Inc. | 568.74M |
| Kezar Life Sciences, Inc. | 23.12M |
| Protara Therapeutics, Inc. | 52.89M |
| Clene, Inc. | 11.48M |